2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Pleural Effusion
1
Pancreatic Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Lung Neoplasms
1
Advanced Solid Tumors
1
Interventions
Thoracoscopy
4
vandetanib
2
Povidone-Iodine
2
Cisplatin
2
dalotuzumab
1
X-Rays
1
Ultrasonography
1
Tyrosine Kinase Inhibitors
1
Tissue Plasminogen Activator
1
Thoracentesis
1
Tenecteplase
1
Surgical Procedures, Operative
1
Saline Solution
1
Receptors, Vascular Endothelial Growth Factor
1
Pleurodesis
1
Pemetrexed
1
Octreotide
1
Naproxen
1
Hyperthermic Intraperitoneal Chemotherapy
1
Gemcitabine
1
Fentanyl
1
Diclofenac
1
Deoxyribonucleases
1
Dasatinib
1
Darbepoetin alfa
1
Clinical Laboratory Techniques
1
Chest Tubes
1
Cdc25C phosphatase (211-221)
1
Catheters, Indwelling
1
Biomarkers
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pleural Effusion
×
Cdc25C phosphatase (211-221)
×
Clear all
NCT00942825
2017-05-24
CBP08-02
CanBas Co. Ltd.
Phase 2
Completed
195 enrolled
8 charts